Gilead Sciences, Inc.

NasdaqGS:GILD Stock Report

Market Cap: US$87.2b

Gilead Sciences Future Growth

Future criteria checks 4/6

Gilead Sciences is forecast to grow earnings and revenue by 36.3% and 2.2% per annum respectively. EPS is expected to grow by 36.9% per annum. Return on equity is forecast to be 34.8% in 3 years.

Key information

36.3%

Earnings growth rate

36.9%

EPS growth rate

Biotechs earnings growth24.0%
Revenue growth rate2.2%
Future return on equity34.8%
Analyst coverage

Good

Last updated11 Jul 2024

Recent future growth updates

Recent updates

Gilead Records Positive Phase III Results In HIV

Jun 22

Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Jun 13
Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors

May 23

We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Apr 22
Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Gilead Sciences: Some Signs Of An Impending Bottom

Apr 22

Gilead Sciences: Realizing Financial Projections Is Key

Mar 20

Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77

Mar 13
Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77

Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution

Mar 01

Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77

Feb 28
Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77

We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated

Feb 15
We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated

Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77

Feb 13
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77

Gilead Sciences: Cheap For A Reason

Feb 10

Gilead Sciences: The Sky Is Not Falling

Feb 01

Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?

Jan 15
Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?

What Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is Not Telling You

Dec 25
What Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is Not Telling You

Earnings and Revenue Growth Forecasts

NasdaqGS:GILD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202628,7166,83210,22510,07324
12/31/202527,9606,30510,0049,79927
12/31/202427,5783878,1366,72127
3/31/202427,4504857,9008,481N/A
12/31/202327,1165,6657,4218,006N/A
9/30/202327,3915,8767,8538,404N/A
6/30/202327,3825,4848,9269,512N/A
3/31/202327,0435,5838,3868,976N/A
12/31/202227,2814,5928,3449,072N/A
9/30/202227,1363,3349,0079,710N/A
6/30/202227,5154,1379,41510,100N/A
3/31/202227,4724,5159,95310,614N/A
12/31/202127,3056,22510,80511,384N/A
9/30/202127,4827,3949,49110,095N/A
6/30/202126,6385,1628,4729,092N/A
3/31/202125,5643018,6989,342N/A
12/31/202024,6891237,5188,168N/A
9/30/202023,1471,2688,1608,832N/A
6/30/202022,174-2578,5109,227N/A
3/31/202022,7164,9628,2449,003N/A
12/31/201922,4495,3868,3199,144N/A
9/30/201922,3652,6938,0398,909N/A
6/30/201922,3575,9557,6398,476N/A
3/31/201922,3205,8926,7587,707N/A
12/31/201822,1275,4557,4768,400N/A
9/30/201822,2811,5877,9128,808N/A
6/30/201823,1972,2088,4329,290N/A
3/31/201824,6903,46410,55911,243N/A
12/31/201726,1074,628N/A11,898N/A
9/30/201727,47811,601N/A12,684N/A
6/30/201728,46612,213N/A14,383N/A
3/31/201729,10112,637N/A15,842N/A
12/31/201630,39013,501N/A17,047N/A
9/30/201631,57615,076N/A18,382N/A
6/30/201632,37116,346N/A18,085N/A
3/31/201632,83917,341N/A18,758N/A
12/31/201532,63918,108N/A21,250N/A
9/30/201531,44716,912N/A18,476N/A
6/30/201529,19415,043N/A18,424N/A
3/31/201527,48514,207N/A16,951N/A
12/31/201424,89012,101N/A12,818N/A
9/30/201420,6969,406N/A10,524N/A
6/30/201417,4377,463N/A7,233N/A
3/31/201413,6694,580N/A4,001N/A
12/31/201311,2023,075N/A3,105N/A
9/30/201310,5853,046N/A3,084N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GILD's forecast earnings growth (36.3% per year) is above the savings rate (2.4%).

Earnings vs Market: GILD's earnings (36.3% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: GILD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GILD's revenue (2.2% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: GILD's revenue (2.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GILD's Return on Equity is forecast to be high in 3 years time (34.8%)


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.